Evaluation of the vitamin-D3, thyroid stimulation hormone, and some biochemical parameters among women with polycystic ovarian syndrome in Baghdad province

Women with anovulation often have "polycystic ovary syndrome (PCOs)", a disorder described by abnormal development of the ovaries. Ultrasound evidence of polycystic ovaries, hyperandrogenism, and prolonged lack of ovulation are all hallmarks of this condition. The wide variety of PCOs anomalies cannot be pinpointed to a single cause. .In the case-control research, there will be a total of 170 female volunteers who are of reproductive age and will be followed medically at Fatima Al Zahraa Women and children Teaching Hospital\ Baghdad. This study lasted from the month of September 2022 until the month of April 2023. Out of the total number of participants, approximately 85 of them were healthy individuals who served as the normal study group, and the residual 85 patients had a clinical diagnosis of polycystic ovarian syndrome. It was decided to get ethical clearance. In order to participate in the research, participants gave their verbal permission. Interviews with each individual patient are conducted in order to collect the necessary data. Vitamin D, TSH, and lipid profile were estimated using ELISA, automated biochemistry analyzer instruments and BMI were evaluated. The study's findings revealed that the mean TSH, BMI, and lipid profile (TC, TG, LDL, and VLDL) were higher among women suffering from PCOs than in healthy women, while the mean vitamin D and HDL were lower in women with POCs than in healthy women. These results indicated a significant difference between study groups concerning all variables except age distribution. Women are at increased risk for PCOs if they have low vitamin D levels, thyroid problems, a high body mass index, as well as hyperlipidemia. Conclution: Low serum levels of vitamin D in women agony from "polycystic ovary syndrome" indicates that a deficiency in the level of this vitamin leads to an exacerbation and development of "polycystic ovary syndrome" in women. The fact that the amount of thyroid-stimulating hormone in the patients was noticeably higher in comparison to the healthy ones suggests that women who have hypothyroidism may be at a greater risk of occurence PCOs. In women who have "polycystic ovary syndrome (PCOs)", having a high body mass index is evidence that obesity plays an active role as a risk factor in the occurence of the condition. When compared to healthy individuals, the group of patients had significantly higher levels of cholesterol and triglycerides, as well as LDL and VLDL, and significantly lower levels of HDL. These results suggest that lipid disorders play a significant role in the development of PCOs in this population. More studies are needed on the relationship of lipid metabolism with PCOS.